The Inflation Reduction Act introduced new requirements for managing Medicare prescription drugs, which have significantly affected Medicare Prescription Drug Plans. While many of these changes are being implemented for upcoming plan years, the impact is expected to continue for the foreseeable future. It’s crucial to stay informed during this period of transition and advise clients to review their plan updates and check their prescriptions against plan formularies to ensure they avoid any unexpected changes or costs.